A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)

Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC

NCT00492206 ·Status: COMPLETED ·Phase: PHASE2

Berzosertib + Topotecan in Relapsed Platinum-Resistant Small-Cell Lung Cancer (DDRiver SCLC 250)

NCT04768296 ·Status: COMPLETED ·Phase: PHASE2

MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma

NCT06097728 ·Status: RECRUITING ·Phase: PHASE3

Japanese Study of Ipilimumab Administered in Combination With Paclitaxel/Carboplatin in Patients With Nonsmall-cell Lung Cancer

NCT01165216 ·Status: COMPLETED ·Phase: PHASE1

A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER

NCT07107490 ·Status: RECRUITING ·Phase: PHASE1

BMS-986012 in Relapsed/Refractory SCLC

NCT02247349 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma

NCT01644994 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of BMS-986012 in Subjects With Small Cell Lung Caner

NCT02949895 ·Status: COMPLETED ·Phase: PHASE1

A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer

NCT05543629 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

An Investigational Immuno-therapy Study of Nivolumab, or Nivolumab in Combination With Ipilimumab, or Placebo in Patients With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based Chemotherapy

NCT02538666 ·Status: COMPLETED ·Phase: PHASE3

Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC

NCT02259621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed

NCT00003053 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy Study of Nivolumab Compared to Docetaxel in Subjects Previously Treated With Advanced or Metastatic Non Small Cell Lung Cancer

NCT02613507 ·Status: COMPLETED ·Phase: PHASE3

Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy

NCT00864331 ·Status: COMPLETED ·Phase: PHASE3

Trial of BMS-986012 in Combination With Platinum and Etoposide

NCT02815592 ·Status: COMPLETED ·Phase: PHASE1

Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer

NCT02481830 ·Status: COMPLETED ·Phase: PHASE3

A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC

NCT07141563 ·Status: COMPLETED

Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer

NCT00850577 ·Status: TERMINATED ·Phase: PHASE2

Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer

NCT05882513 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer

NCT04025879 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC

NCT03527108 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

The Study is Being Conducted to Evaluate the Efficacy and Safety of SHR-1316 in Combination With Chemo-radiotherapy in Patients With LS-SCLC.

NCT04691063 ·Status: UNKNOWN ·Phase: PHASE3

Olvi-Vec Combined With Platinum Plus Etoposide Therapy in Patients With Late Phase SCLC

NCT07136285 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC

NCT06258642 ·Status: RECRUITING ·Phase: NA

Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)

NCT01059188 ·Status: COMPLETED ·Phase: PHASE2